Fluorometric Determination of Bopindolol and Celiprolol in Pharmaceutical Preparations and Biological Fluids

被引:4
作者
Belal, F. [1 ]
El-Din, M. Sharaf [1 ]
Aly, F. [2 ]
Hefnawy, M. [3 ]
El-Awady, M. [1 ]
机构
[1] Univ Mansoura, Fac Pharm, Dept Analyt Chem, Mansoura 35516, Egypt
[2] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11495, Saudi Arabia
[3] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
关键词
Bopindolol; Celiprolol; Fluorometry; Applications; Pharmaceutical preparations; Content uniformity test; Biological fluids; PERFORMANCE LIQUID-CHROMATOGRAPHY; BETA-BLOCKERS; CAPILLARY ELECTROCHROMATOGRAPHY; MASS-SPECTROMETRY; CHIRAL SEPARATION; STATIONARY-PHASE; DRUGS; ELECTROPHORESIS; PLASMA; HPLC;
D O I
10.1007/s10895-012-1053-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Two sensitive fluorometric methods were developed for the determination of both bopindolol malonate (BOP) and celiprolol HCl (CLP) based on measuring their native fluorescence in methanol and acetonitrile, respectively. For BOP, the fluorescence was measured at 316 nm after excitation at 278 nm. The proposed method was successfully applied to the assay of commercial tablets as well as content uniformity testing. For CLP, the fluorescence was enhanced by the addition of carboxymethylcellulose solution and measured at 455 nm after excitation at 339 nm. The method was successfully applied to the analysis of CLP in tablets and biological fluids. In both methods, interference likely to be introduced from co-formulated, co-administered, or chemically related drugs was studied. The results were statistically compared with those obtained by reference methods and were found to be in good agreement.
引用
收藏
页码:1141 / 1150
页数:10
相关论文
共 36 条
[1]  
Abu-Shadi H. A., 1995, Egyptian Journal of Pharmaceutical Sciences, V36, P393
[2]  
[Anonymous], 2007, US PHARM
[3]  
BANERJEE S K, 1989, Indian Journal of Pharmaceutical Sciences, V51, P74
[4]   Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography [J].
Caudron, E ;
Laurent, S ;
Billaud, EM ;
Prognon, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 801 (02) :339-345
[5]   Simultaneous determination of thirteen β-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection [J].
Delamoye, M ;
Duverneuil, C ;
Paraire, F ;
de Mazancourt, P ;
Alvarez, JC .
FORENSIC SCIENCE INTERNATIONAL, 2004, 141 (01) :23-31
[6]   Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography mass spectrometry with scan-to-scan polarity switching [J].
Deventer, K ;
Van Eenoo, P ;
Delbeke, FT .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (02) :90-98
[7]   Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy [J].
Gonzalez, Oskar ;
Maria Alonso, Rosa ;
Ferreiros, Nerea ;
Weinmann, Wolfgang ;
Zimmermann, Ralf ;
Dresen, Sebastian .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (3-4) :243-252
[8]  
Grobuschek N, 2002, J SEP SCI, V25, P1297, DOI 10.1002/1615-9314(20021101)25:15/17<1297::AID-JSSC1297>3.0.CO
[9]  
2-X
[10]   REVERSED-PHASE LIQUID-CHROMATOGRAPHY OF BETA-ADRENERGIC BLOCKING-DRUGS IN THE PRESENCE OF A TAILING SUPPRESSOR [J].
HAMOIR, T ;
VERLINDEN, Y ;
MASSART, DL .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1994, 32 (01) :14-20